|
||||||
|
 | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
|
Gene: ENSG00000167110 |
Summary for GOLGA2 |
 Gene summary |
| Gene information | Ensembl ID | ENSG00000167110 | Gene symbol | GOLGA2 |
| Gene name | golgin A2 | |
| HGNC | 4425 | |
| Entrez ID | 2801 | |
| Gene type | protein_coding | |
| Synonyms | GOLGA2|GM130|golgin-95 | |
| UniProtAcc | Q08379 |
| Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
| Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for GOLGA2 |
| AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure. ∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
 |
| Landscape of gene expressions across multiple cancer types. |
 |
| Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| Differentially expressed gene analysis between tumor female and normal female samples. |
 |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| GOLGA2 | 6.78e+03 | 1.01e+00 | 1.62e-01 | 6.23e+00 | 4.56e-10 | 2.87e-09 | KICH |
Top |
Sex-biased somatic mutation for GOLGA2 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for GOLGA2 |
| Landscape of DNA methylation across multiple cancer types. |
 |
| Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LUSC | cg13614286 | chr9:128276048 | CGI:chr9:128275312-128276416 | promoter | 1.57e-01 | 2.16e-02 | 4.11e+00 | 4.00e-05 | 5.36e-04 | 1.35e-01 |
| CHOL | cg13614286 | chr9:128276048 | CGI:chr9:128275312-128276416 | promoter | 1.24e-01 | 2.09e-02 | 2.88e+00 | 4.04e-03 | 1.47e-02 | 1.04e-01 |
| Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
Top |
Exon skipping events with PSI in TCGA for GOLGA2 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
| Landscape of exon skipping events across multiple cancer types. |
 |
| Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| KIRC | exon_skip_507438 | 4.84e-01 | 5.90e-01 | -6.41e+00 | 1.44e-10 | 2.83e-09 | -1.06e-01 |
| BLCA | exon_skip_507444 | 2.51e-01 | 6.05e-01 | -2.53e+00 | 1.12e-02 | 2.25e-02 | -3.53e-01 |
| ESCA | exon_skip_507438 | 5.43e-01 | 7.25e-01 | -3.50e+00 | 4.63e-04 | 8.25e-03 | -1.82e-01 |
| CHOL | exon_skip_507438 | 4.35e-01 | 7.16e-01 | -2.80e+00 | 5.07e-03 | 1.42e-02 | -2.81e-01 |
| Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
| BRCA | exon_skip_507444 | 2.92e-01 | 6.13e-01 | -1.56e+01 | 8.65e-55 | 1.41e-51 | -3.21e-01 |
| READ | exon_skip_507438 | 4.36e-01 | 6.45e-01 | -3.62e+00 | 3.00e-04 | 4.67e-03 | -2.09e-01 |
| KICH | exon_skip_507444 | 4.05e-01 | 5.51e-01 | -3.57e+00 | 3.59e-04 | 2.72e-03 | -1.46e-01 |
Top |
RNA A-to-I editing events in TCGA for GOLGA2 |
| ∗Please access CAeditome for RNA editing annotation. |
| Landscape of RNA editing events across multiple cancer types. |
 |
| Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| LUAD | GOLGA2-202 | chr9_128270272_- | 5.21e-01 | 2.93e-01 | 2.61e+00 | 9.02e-03 | 2.77e-02 | 2.27e-01 |
| ESCA | GOLGA2-202 | chr9_128269100_- | 4.05e-01 | 2.93e-01 | 1.97e+00 | 4.83e-02 | 4.99e-02 | 1.12e-01 |
| Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
| Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for GOLGA2 |
| TFs related to GOLGA2. ∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| PCPG | ZNF79 | GOLGA2 | 4.25e+00 | 9.88e-01 | 2.99e+00 | 1.17e-03 | Male-biased |
| PCPG | ZNF879 | GOLGA2 | 4.23e+00 | 9.87e-01 | 3.08e+00 | 1.97e-03 | Male-biased |
| GOLGA2 related gene. ∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for GOLGA2 |
| RBPs related to ES in GOLGA2. ∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
 |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| ACC | RBM3 | exon_skip_507424 | 1.31e+01 | 9.98e-01 | 1.24e+01 | 1.62e-03 | Male-biased |
| UVM | HNRNPA1L2 | exon_skip_507439 | 1.24e+01 | 2.16e-04 | 1.31e+01 | 9.99e-01 | Female-biased |
| UVM | RBM24 | exon_skip_507424 | 7.26e+00 | 9.85e-01 | 6.85e+00 | 2.31e-03 | Male-biased |
| UVM | RBM3 | exon_skip_507424 | 1.36e+01 | 9.99e-01 | 1.31e+01 | 5.35e-04 | Male-biased |
| THYM | HNRNPA1L2 | exon_skip_507439 | 1.32e+01 | 9.99e-01 | 1.27e+01 | 8.28e-04 | Male-biased |
| LIHC | HNRNPA1L2 | exon_skip_507439 | 1.28e+01 | 2.17e-03 | 1.34e+01 | 9.98e-01 | Female-biased |
| LIHC | RBM3 | exon_skip_507424 | 1.33e+01 | 9.99e-01 | 1.25e+01 | 6.95e-04 | Male-biased |
| LUSC | HNRNPA1L2 | exon_skip_507439 | 1.29e+01 | 5.42e-03 | 1.33e+01 | 9.94e-01 | Female-biased |
| LUSC | RBM3 | exon_skip_507421 | 1.25e+01 | 1.08e-03 | 1.31e+01 | 9.99e-01 | Female-biased |
| LUAD | HNRNPA1L2 | exon_skip_507439 | 1.29e+01 | 9.81e-01 | 1.27e+01 | 1.90e-02 | Male-biased |
| LUAD | PCBP2 | exon_skip_507440 | 7.93e+00 | 1.19e-02 | 8.25e+00 | 9.80e-01 | Female-biased |
| LUAD | PPRC1 | exon_skip_507416 | 1.08e+01 | 3.36e-03 | 1.12e+01 | 9.96e-01 | Female-biased |
| LUAD | RBM4 | exon_skip_507416 | 8.25e+00 | 1.29e-02 | 8.56e+00 | 9.81e-01 | Female-biased |
| LUAD | RBM8A | exon_skip_507416 | 1.09e+01 | 2.04e-03 | 1.14e+01 | 9.97e-01 | Female-biased |
| KIRP | PPRC1 | exon_skip_507416 | 1.07e+01 | 7.87e-03 | 1.10e+01 | 9.91e-01 | Female-biased |
| KIRP | RBM8A | exon_skip_507416 | 1.08e+01 | 5.56e-03 | 1.12e+01 | 9.93e-01 | Female-biased |
| BRCA | RBM3 | exon_skip_507421 | 1.31e+01 | 9.83e-01 | 1.26e+01 | 1.65e-02 | Male-biased |
| ESCA | RBM3 | exon_skip_507424 | 1.36e+01 | 9.99e-01 | 1.29e+01 | 1.26e-03 | Male-biased |
| READ | RBM3 | exon_skip_507421 | 1.24e+01 | 5.21e-04 | 1.30e+01 | 9.99e-01 | Female-biased |
| READ | RBM3 | exon_skip_507424 | 1.30e+01 | 8.71e-04 | 1.36e+01 | 9.99e-01 | Female-biased |
| THCA | EIF4B | exon_skip_507432 | 1.05e+01 | 9.89e-01 | 1.02e+01 | 9.46e-03 | Male-biased |
| THCA | PPRC1 | exon_skip_507416 | 1.10e+01 | 9.98e-01 | 1.05e+01 | 1.35e-03 | Male-biased |
| THCA | RBM8A | exon_skip_507416 | 1.11e+01 | 9.98e-01 | 1.06e+01 | 6.43e-04 | Male-biased |
| MESO | EIF4B | exon_skip_507432 | 1.02e+01 | 8.80e-03 | 1.05e+01 | 9.90e-01 | Female-biased |
| MESO | PPRC1 | exon_skip_507416 | 1.05e+01 | 2.69e-03 | 1.10e+01 | 9.96e-01 | Female-biased |
| MESO | RBM3 | exon_skip_507421 | 1.33e+01 | 9.99e-01 | 1.27e+01 | 1.12e-03 | Male-biased |
| MESO | RBM8A | exon_skip_507416 | 1.08e+01 | 5.02e-03 | 1.12e+01 | 9.94e-01 | Female-biased |
| LGG | HNRNPA1L2 | exon_skip_507439 | 1.28e+01 | 9.92e-01 | 1.25e+01 | 7.30e-03 | Male-biased |
| LGG | PCBP2 | exon_skip_507441 | 8.33e+00 | 9.90e-01 | 7.89e+00 | 3.21e-03 | Male-biased |
| LGG | PPRC1 | exon_skip_507416 | 1.15e+01 | 9.96e-01 | 1.10e+01 | 2.93e-03 | Male-biased |
| LGG | RBM3 | exon_skip_507421 | 1.30e+01 | 9.98e-01 | 1.25e+01 | 1.35e-03 | Male-biased |
| LGG | RBM8A | exon_skip_507416 | 1.13e+01 | 9.94e-01 | 1.09e+01 | 5.05e-03 | Male-biased |
| GBM | PPRC1 | exon_skip_507416 | 1.08e+01 | 5.68e-03 | 1.12e+01 | 9.93e-01 | Female-biased |
| GBM | RBM3 | exon_skip_507424 | 1.35e+01 | 9.99e-01 | 1.29e+01 | 7.16e-04 | Male-biased |
| GBM | RBM8A | exon_skip_507416 | 1.07e+01 | 7.56e-03 | 1.10e+01 | 9.91e-01 | Female-biased |
| PAAD | RBM3 | exon_skip_507421 | 1.27e+01 | 9.67e-04 | 1.32e+01 | 9.99e-01 | Female-biased |
| KIRC | FMR1 | exon_skip_507444 | 8.45e+00 | 9.83e-01 | 8.14e+00 | 1.02e-02 | Male-biased |
| KIRC | PPRC1 | exon_skip_507416 | 1.11e+01 | 2.24e-03 | 1.16e+01 | 9.97e-01 | Female-biased |
| KIRC | RBM4 | exon_skip_507416 | 8.31e+00 | 7.53e-03 | 8.65e+00 | 9.87e-01 | Female-biased |
| KIRC | RBM8A | exon_skip_507416 | 1.12e+01 | 3.30e-03 | 1.16e+01 | 9.96e-01 | Female-biased |
| KICH | HNRNPA1L2 | exon_skip_507439 | 1.27e+01 | 2.14e-03 | 1.31e+01 | 9.98e-01 | Female-biased |
| KICH | RBM3 | exon_skip_507424 | 1.37e+01 | 9.99e-01 | 1.31e+01 | 9.57e-04 | Male-biased |
| BLCA | HNRNPA1L2 | exon_skip_507439 | 1.30e+01 | 4.49e-03 | 1.34e+01 | 9.95e-01 | Female-biased |
| BLCA | PPRC1 | exon_skip_507416 | 1.06e+01 | 5.90e-03 | 1.10e+01 | 9.93e-01 | Female-biased |
| BLCA | RBM3 | exon_skip_507421 | 1.25e+01 | 1.57e-03 | 1.31e+01 | 9.98e-01 | Female-biased |
| BLCA | RBM8A | exon_skip_507416 | 1.07e+01 | 1.80e-02 | 1.10e+01 | 9.81e-01 | Female-biased |
| SKCM | RBM3 | exon_skip_507421 | 1.27e+01 | 2.61e-03 | 1.32e+01 | 9.97e-01 | Female-biased |
| HNSC | EIF4B | exon_skip_507432 | 1.01e+01 | 5.12e-03 | 1.05e+01 | 9.94e-01 | Female-biased |
| HNSC | PCBP2 | exon_skip_507440 | 7.79e+00 | 3.06e-03 | 8.23e+00 | 9.89e-01 | Female-biased |
| SARC | RBM3 | exon_skip_507421 | 1.34e+01 | 9.96e-01 | 1.29e+01 | 3.52e-03 | Male-biased |
| GOLGA2 related ES. ∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
| Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
| ENSG00000167110 | AC073957.3,hsa-mir-150,GOLGA2 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000167110 | AC084018.2,hsa-mir-150,GOLGA2 | Female-specific ceRNA | TCGA-KICH |
| ENSG00000167110 | AL158825.2,hsa-mir-372,GOLGA2 | Female-specific ceRNA | TCGA-KICH |
Top |
Sex-biased eQTL regulation of gene |
| Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
| Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs7861747 | chr9:129798300:G:A | - | 0.259777725747356 | 0.00110471059548085 | GBM | Female-baised eQTL |
| rs11244207 | chr9:130947709:A:C | - | 0.169841913308359 | 0.0270486124953844 | GBM | Female-baised eQTL |
| rs4837732 | chr9:120202940:C:T | - | -0.183328729008775 | 0.0307096992680956 | GBM | Female-baised eQTL |
| rs2058480 | chr9:120203301:G:A | - | -0.183328729008775 | 0.0307096992680956 | GBM | Female-baised eQTL |
| rs2058481 | chr9:120203381:A:C | - | -0.183328729008775 | 0.0307096992680956 | GBM | Female-baised eQTL |
| rs10867090 | chr9:137953733:T:G | - | 0.0730153540730997 | 0.0162503775583287 | COAD | Female-baised eQTL |
| rs28417558 | chr9:137952766:T:G | - | 0.0730309886140432 | 0.016878965015059 | COAD | Female-baised eQTL |
| rs7046931 | chr9:137928909:G:A | - | 0.070857641774565 | 0.0174949811188477 | COAD | Female-baised eQTL |
| rs7034441 | chr9:137952898:C:T | - | 0.0710179167924552 | 0.0190524976595356 | COAD | Female-baised eQTL |
| rs7868607 | chr9:137932059:C:A | - | 0.0707488398988351 | 0.01992614927529 | COAD | Female-baised eQTL |
| rs11137330 | chr9:137981519:C:T | - | 0.0712426427472678 | 0.020355839327862 | COAD | Female-baised eQTL |
| rs10732689 | chr9:137982275:A:T | - | 0.0712426427472678 | 0.020355839327862 | COAD | Female-baised eQTL |
| rs7045820 | chr9:137933089:C:T | - | 0.0700435122812603 | 0.0230328228542135 | COAD | Female-baised eQTL |
| rs7023861 | chr9:137936139:G:A | - | 0.0700435122812603 | 0.0230328228542135 | COAD | Female-baised eQTL |
| rs12001491 | chr9:137986143:C:T | - | 0.0693702083085428 | 0.0241666615635073 | COAD | Female-baised eQTL |
| rs7034745 | chr9:137986862:A:C | - | 0.0685853759487544 | 0.0296018757007682 | COAD | Female-baised eQTL |
| rs4469543 | chr9:137934686:C:T | - | 0.0623998548497968 | 0.0388464453872386 | COAD | Female-baised eQTL |
| rs11243447 | chr9:131599712:A:G | - | 0.0534033924884277 | 0.0489721268343845 | COAD | Female-baised eQTL |
| Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs4838018 | chr9:122850528:C:T | - | 0.0639229594875381 | 0.014227424980141 | HNSC | Male-baised eQTL |
| rs733329 | chr9:122861885:T:C | - | 0.0639229594875381 | 0.014227424980141 | HNSC | Male-baised eQTL |
| rs7872023 | chr9:122870647:T:G | - | 0.0637875707084753 | 0.0142352411043893 | HNSC | Male-baised eQTL |
| rs61167274 | chr9:122884220:G:T | - | 0.0637429110319222 | 0.0144317545748306 | HNSC | Male-baised eQTL |
| rs10985805 | chr9:122881756:C:T | - | 0.0658300810252843 | 0.0172162126065789 | HNSC | Male-baised eQTL |
| rs3824535 | chr9:122921577:T:G | - | 0.0604146473024051 | 0.0259305735728316 | HNSC | Male-baised eQTL |
| rs7350160 | chr9:122886225:A:G | - | 0.0632268553406188 | 0.0259876884653285 | HNSC | Male-baised eQTL |
| rs60753674 | chr9:122887102:C:T | - | 0.0632268553406188 | 0.0259876884653285 | HNSC | Male-baised eQTL |
| rs4838019 | chr9:122891366:G:C | - | 0.0596460686801858 | 0.0283688426469348 | HNSC | Male-baised eQTL |
| rs633858 | chr9:126963214:A:G | - | -0.0956296956879968 | 0.00721084774301971 | BLCA | Male-baised eQTL |
| rs446038 | chr9:121331662:A:G | - | -0.0737767783195742 | 0.00909314590146927 | BLCA | Male-baised eQTL |
| rs364814 | chr9:121331736:A:G | - | -0.0715648542785543 | 0.0121102409978174 | BLCA | Male-baised eQTL |
| rs306771 | chr9:121328857:G:A | - | -0.0649868037475265 | 0.0128117787477308 | BLCA | Male-baised eQTL |
| rs306765 | chr9:121322993:A:G | - | -0.0651870500022542 | 0.0331704973733098 | BLCA | Male-baised eQTL |
| rs306769 | chr9:121326490:T:C | - | -0.0639679934610322 | 0.0387011664786013 | BLCA | Male-baised eQTL |
| rs306770 | chr9:121328506:G:A | - | -0.0599105909865066 | 0.0410175380065853 | BLCA | Male-baised eQTL |
| rs1468672 | chr9:121047459:G:A | - | -0.0541510280071955 | 0.0460307022319048 | BLCA | Male-baised eQTL |
| rs7037269 | chr9:135339042:T:A | - | -0.0696474010866184 | 0.0219197874358381 | LUAD | Male-baised eQTL |
| rs4842253 | chr9:135337832:C:A | - | -0.06819073147499 | 0.034013031987452 | LUAD | Male-baised eQTL |
| rs914410 | chr9:135338079:G:A | - | -0.06819073147499 | 0.034013031987452 | LUAD | Male-baised eQTL |
| rs6538017 | chr9:135340461:T:C | - | -0.0676770067000285 | 0.0400191064948439 | LUAD | Male-baised eQTL |
| rs1810884 | chr9:135338150:A:C | - | -0.0658463227232289 | 0.0405265204987235 | LUAD | Male-baised eQTL |
| rs7024546 | chr9:122934667:G:C | - | 0.085613383992377 | 0.0493305062828533 | COAD | Male-baised eQTL |
| Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
| Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
| eQTM | Description |
| Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
| Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
| Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| exon_skip_507438 | chr9:128267193:128267274 | In-frame | rs1891728 | chr9:127546564:T:C | Distant downstream | 0.0262185340004732 | 0.0484513689724342 | THCA | Female-baised sQTL |
| Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
| Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
| Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
| Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
| Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of GOLGA2 |
| Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |
